JPH10504015A - 抗再狭窄タンパク質 - Google Patents

抗再狭窄タンパク質

Info

Publication number
JPH10504015A
JPH10504015A JP7526302A JP52630295A JPH10504015A JP H10504015 A JPH10504015 A JP H10504015A JP 7526302 A JP7526302 A JP 7526302A JP 52630295 A JP52630295 A JP 52630295A JP H10504015 A JPH10504015 A JP H10504015A
Authority
JP
Japan
Prior art keywords
serp
analog
amino acid
protein
item
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP7526302A
Other languages
English (en)
Japanese (ja)
Inventor
マクファーデン，ディ・グラント
ルーカス，アレクサンドラ
Original Assignee
マクファーデン，ディ・グラント
ルーカス，アレクサンドラ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by マクファーデン，ディ・グラント, ルーカス，アレクサンドラ filed Critical マクファーデン，ディ・グラント
Publication of JPH10504015A publication Critical patent/JPH10504015A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Passenger Equipment (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
JP7526302A 1994-04-08 1994-04-08 抗再狭窄タンパク質 Withdrawn JPH10504015A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/003895 WO1995027503A1 (en) 1994-04-08 1994-04-08 Antirestenosis protein

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2005194048A Division JP2005306883A (ja) 2005-07-01 2005-07-01 抗再狭窄タンパク質

Publications (1)

Publication Number Publication Date
JPH10504015A true JPH10504015A (ja) 1998-04-14

Family

ID=22242439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP7526302A Withdrawn JPH10504015A (ja) 1994-04-08 1994-04-08 抗再狭窄タンパク質

Country Status (10)

Country Link
US (1) US5686409A (pt)
EP (1) EP0754054B1 (pt)
JP (1) JPH10504015A (pt)
AT (1) ATE219943T1 (pt)
CA (1) CA2187444C (pt)
DE (1) DE69430924T2 (pt)
DK (1) DK0754054T3 (pt)
ES (1) ES2176250T3 (pt)
PT (1) PT754054E (pt)
WO (1) WO1995027503A1 (pt)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003508489A (ja) * 1999-09-09 2003-03-04 ハダジツト・メデイカル・リサーチ・サービシズ・アンド・デベロツプメント・カンパニー・リミテツド 創傷治癒の増進
JP2013527125A (ja) * 2009-09-16 2013-06-27 バイロン セラピューティクス インコーポレーテッド 心臓ステント移植を受ける患者を治療する方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939525A (en) * 1995-03-27 1999-08-17 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
US6818016B1 (en) * 1997-06-27 2004-11-16 The Regents Of The University Of Michigan Methods for coating stents with DNA and expression of recombinant genes from DNA coated stents in vivo
DE60020727T2 (de) 1999-10-27 2006-05-04 Robert London Zhong Zusammensetzung zur vorbeugung und behandlung von transplantatabstossung
WO2001039790A1 (en) * 1999-12-02 2001-06-07 Viron Therapeutics, Inc. Methods of treating inflammation and compositions therefor
EP1365798B1 (en) * 2000-09-29 2009-12-30 Viron Therapeutics, Inc. Use of serp-1 in combination with an immunosuppressant for treating arthritis
EP2357002A1 (en) * 2000-10-11 2011-08-17 Viron Therapeutics, Inc. Nucleic acid molecules and polypeptides for immune modulation
AU2002215727B9 (en) * 2000-12-04 2008-02-21 Viron Therapeutics Inc. Immunomodulatory protein derived from the yaba monkey tumor virus
US7718368B2 (en) * 2000-12-04 2010-05-18 Viron Therapeutics Inc. Immunomodulatory protein and useful embodiments thereof
US7285530B2 (en) * 2004-10-21 2007-10-23 Viron Therapeutics, Inc. Use of SERP-1 as an antiplatelet agent
US8251876B2 (en) 2008-04-22 2012-08-28 Hill-Rom Services, Inc. Breathing exercise apparatus
US9180271B2 (en) 2012-03-05 2015-11-10 Hill-Rom Services Pte. Ltd. Respiratory therapy device having standard and oscillatory PEP with nebulizer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5171217A (en) * 1991-02-28 1992-12-15 Indiana University Foundation Method for delivery of smooth muscle cell inhibitors

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003508489A (ja) * 1999-09-09 2003-03-04 ハダジツト・メデイカル・リサーチ・サービシズ・アンド・デベロツプメント・カンパニー・リミテツド 創傷治癒の増進
JP2013527125A (ja) * 2009-09-16 2013-06-27 バイロン セラピューティクス インコーポレーテッド 心臓ステント移植を受ける患者を治療する方法

Also Published As

Publication number Publication date
EP0754054B1 (en) 2002-07-03
DE69430924T2 (de) 2003-02-27
CA2187444C (en) 2008-07-08
US5686409A (en) 1997-11-11
DE69430924D1 (de) 2002-08-08
CA2187444A1 (en) 1995-10-19
DK0754054T3 (da) 2002-10-14
ATE219943T1 (de) 2002-07-15
ES2176250T3 (es) 2002-12-01
EP0754054A1 (en) 1997-01-22
WO1995027503A1 (en) 1995-10-19
PT754054E (pt) 2002-10-31

Similar Documents

Publication Publication Date Title
EP0567566B1 (en) Methods for treating tumor necrosis factor mediated diseases
RU2428479C2 (ru) Применение слитого конструкта тимп-гфи и способ лечения повреждений кожи для предотвращения или ингибирования образования рубца
JPH10504015A (ja) 抗再狭窄タンパク質
JPH02262593A (ja) 血管発生病の処置に有用な薬剤及び新規な蛋白質
US7745396B2 (en) Use of SERP-1 as an antiplatelet agent
KR20050004809A (ko) 말초 맥관 질환 치료 및/또는 예방에 사용되는 ｉｌ-18저해제
JP2006151996A (ja) 組織因子活性インヒビターｔｆｐｉおよびｔｆｐｉ−２のキメラタンパク質および変異体
EA005410B1 (ru) Применение ингибиторов il-18 для лечения и/или предотвращения атеросклероза
US20050063948A1 (en) Methods for targeting interleukin-12 to malignant endothelium
CA2136953C (en) A method for using lipoprotein associated coagulation inhibitor to treat sepsis
JP2007525972A (ja) エンドスタチンのｎ末端からの抗血管新生性ペプチド
US20050282737A1 (en) Procollagen (III) propeptides and related substances for treating fibrotic diseases
JP2002179590A (ja) 再活性化酸素種に対する防御剤の使用
EP1358888A1 (en) The human peptide antibiotic LL-37/hCAP-18 is an inducer of angiogenesis
AU706582B2 (en) Angiogenic inhibitor containing tissue factor pathway inhibitor
JP3030386B2 (ja) 抗ガン剤
JP2002516339A (ja) ＬＡＩＴ／ｓＣＤ１４−蛋白質による抗生物質蛋白質およびペプチドの誘導
JP2005526122A (ja) 抗血管新生療法のためのならびに繊維素溶解療法のための８−プレニルフラバノンの使用
JP2008007512A (ja) 動脈狭窄の減弱方法
JP2005306883A (ja) 抗再狭窄タンパク質
US20060275303A1 (en) Modulating angiogenesis using LL-37/HCAP-18
CA2557884C (en) An agent for promoting induction of vascular differentiation, comprising hepatocyte growth factor
EP0560998A1 (en) Medicine for preventing and treating bleeding tendency
US20120076754A1 (en) Use of IL-17 Polypeptides for Use in the Prevention or Treatment of Atherosclerosis
LeRoy et al. PROTEINASES IN THE FIBROSIS OF SYSTEMIC SCLEROSIS

Legal Events

Date Code Title Description
A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20040720

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20041019

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20041206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20050308

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050606

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20050713